1. Skip to content
  2. Skip to main menu
  3. Skip to more DW sites

German pharma firms seek COVID drugs funding

02:32

This browser does not support the video element.

Tabea Mergenthaler
May 19, 2021

Thanks to generous funding, German pharma firms set a blistering pace in developing a shot against COVID-19. Therapeutic drugs against the disease , however, got left left behind. And it’s likely to stay that way.

Skip next section DW's Top Story

DW's Top Story

Skip next section More stories from DW

More stories from DW